These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK; Medina D Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257 [TBL] [Abstract][Full Text] [Related]
9. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27. Decker T; Schneller F; Hipp S; Miething C; Jahn T; Duyster J; Peschel C Leukemia; 2002 Mar; 16(3):327-34. PubMed ID: 11896535 [TBL] [Abstract][Full Text] [Related]
10. Cyclin D3 is dispensable for human diffuse large B-cell lymphoma survival and growth: evidence for redundancy with cyclin E. Gumina MR; Xu C; Chiles TC Cell Cycle; 2010 Feb; 9(4):820-8. PubMed ID: 20107311 [TBL] [Abstract][Full Text] [Related]
11. Mouse development and cell proliferation in the absence of D-cyclins. Kozar K; Ciemerych MA; Rebel VI; Shigematsu H; Zagozdzon A; Sicinska E; Geng Y; Yu Q; Bhattacharya S; Bronson RT; Akashi K; Sicinski P Cell; 2004 Aug; 118(4):477-91. PubMed ID: 15315760 [TBL] [Abstract][Full Text] [Related]
12. A requirement for cyclin D3-cyclin-dependent kinase (cdk)-4 assembly in the cyclic adenosine monophosphate-dependent proliferation of thyrocytes. Depoortere F; Van Keymeulen A; Lukas J; Costagliola S; Bartkova J; Dumont JE; Bartek J; Roger PP; Dremier S J Cell Biol; 1998 Mar; 140(6):1427-39. PubMed ID: 9508775 [TBL] [Abstract][Full Text] [Related]
13. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation. Rickheim DG; Nelsen CJ; Fassett JT; Timchenko NA; Hansen LK; Albrecht JH Hepatology; 2002 Jul; 36(1):30-8. PubMed ID: 12085346 [TBL] [Abstract][Full Text] [Related]
14. Expression of D-type cyclins in normal and neoplastic rat pituitary. Qian X; Kulig E; Jin L; Lloyd RV Endocrinology; 1998 Apr; 139(4):2058-67. PubMed ID: 9528994 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1). Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520 [TBL] [Abstract][Full Text] [Related]
16. Cdk4 integrates growth stimulatory and inhibitory signals during G1 phase of hematopoietic cells. Ando K; Griffin JD Oncogene; 1995 Feb; 10(4):751-5. PubMed ID: 7862452 [TBL] [Abstract][Full Text] [Related]
17. Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40. Lam EW; Glassford J; Banerji L; Thomas NS; Sicinski P; Klaus GG J Biol Chem; 2000 Feb; 275(5):3479-84. PubMed ID: 10652342 [TBL] [Abstract][Full Text] [Related]
18. Development of mice expressing a single D-type cyclin. Ciemerych MA; Kenney AM; Sicinska E; Kalaszczynska I; Bronson RT; Rowitch DH; Gardner H; Sicinski P Genes Dev; 2002 Dec; 16(24):3277-89. PubMed ID: 12502747 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of Cdk6-cyclin D3 highly sensitizes cells to physical and chemical transformation. Chen Q; Lin J; Jinno S; Okayama H Oncogene; 2003 Feb; 22(7):992-1001. PubMed ID: 12592386 [TBL] [Abstract][Full Text] [Related]
20. Regulation of the catalytic subunit (p34PSK-J3/cdk4) for the major D-type cyclin in mature B lymphocytes. Tanguay DA; Chiles TC J Immunol; 1996 Jan; 156(2):539-48. PubMed ID: 8543804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]